Vascular Dynamics to initiate resistant hypertension trial

08:20 EDT 16 Aug 2017 | CentreWatch

Vascular Dynamics, Inc., (VDI) a privately held medical device company developing novel solutions for the treatment of hypertension, announces that the FDA has approved the company’s Investigational Device Exemption (IDE) application to initiate its pivotal trial for its MobiusHD System for the treatment of resistant hypertension. The CALM (Controlling and Lowering Blood Pressure with MobiusHD) 2 […]

The post Vascular Dynamics to initiate resistant hypertension trial appeared first on CenterWatch News Online.

Original Article: Vascular Dynamics to initiate resistant hypertension trial


More From BioPortfolio on "Vascular Dynamics to initiate resistant hypertension trial"

Quick Search


Relevant Topics

Vascular relates to blood vessels (Oxford Medical Dictionary) and can be used to describe the supply of blood, a disease affecting the blood vessels or molecules associated with these structures. For example, <!--LGfEGNT2Lhm-->atherosclerosis ...

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Adempas (riociguat)
The United States Food and Drug Administration (FDA) has approved on October 8th 2013 Adempas® (riociguat) tablets for: (i) the treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) (WHO* Group 4) after ...